Tuesday 5 March 2019 (8th Week, Hilary Term)

• 13:00 - Title TBC
  Dr Benjamin Fairfax (Molecular Oncology, MRC WIMM)
  Molecular Haematology Unit, WIMM

Thursday 9 January 2020 (-1st Week, Hilary Term)

• 16:30 - Defining correlates of clinical benefit and autoimmune adverse events secondary to Immune Checkpoint blockade
  Dr Benjamin Fairfax (Molecular Oncology, MRC WIMM)
  BRC3 Gastroenterology and Mucosal Immunity Theme Seminars
• 16:30 - Defining correlates of clinical benefit and autoimmune adverse events secondary to Immune Checkpoint blockade
  Dr Benjamin Fairfax (Molecular Oncology, MRC WIMM)
  Experimental Medicine TGU Seminars